AdvaMed’s Medical Innovation Agenda for the 118th Congress
AdvaMed’s medtech priorities for the 118th Congress highlight opportunities to address the most important issues facing patients and the medical technology industry today.
Global & Trade
Learn more about our Global Affairs work.
China: Key Regulatory Changes from 2022 and Look Ahead to 2023
Get the latest on NMPA’s updated guidance for the clinical evaluation of medical devices.
Medical Technology Donations for the Turkish Earthquake Response
AdvaMed and its member companies are working with the U.S. government on medtech donations for humanitarian aid following the devastating earthquakes in southeast Turkey and northern Syria.
Regulations and Reimbursement of Software as a Medical Device in Europe- Part1
This publication series explores “Software as a Medical Device (SaMD),” its challenges and the ways regulatory bodies try to address them, as well as the expected development of regulations related…
AdvaMed Statement on United States-India Trade Policy Forum
AdvaMed issued a statement from President and CEO Scott Whitaker on the Joint Statement issued by the United States Trade Representative and India’s Ministry of Commerce & Industry at the…
AdvaMed’s Top 10 Medtech Wins in 2022
From MDUFA V and the major investments in semiconductor chip manufacturing in the CHIPS Act, to addressing global supply chain issues and supporting our AdvaMed Accel companies, 2022 was a…
The Global Medtech Industry: Rewiring Medtech in a Post-Pandemic World
This white paper from IQVIA – an associate member of AdvaMed – discusses how global markets and specific therapeutic areas are poised for growth over the next decade.